# Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER

> **NCT06528743** · NA · RECRUITING · sponsor: **The Netherlands Cancer Institute** · enrollment: 34 (estimated)

## Conditions studied

- Patients With Non-small-cell Lung Cancer

## Interventions

- **RADIATION:** RT (5x6 Gy) to the primary tumor and, if indicated, to lymph node and/or distant metastases.

## Key facts

- **NCT ID:** NCT06528743
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-08
- **Primary completion:** 2028-08-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528743, "Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT06528743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*